BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34598309)

  • 21. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
    Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
    [No Abstract]   [Full Text] [Related]  

  • 22. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
    Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
    Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
    Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
    Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma.
    Bravo-Perez C; Fernández-Caballero M; Soler-Espejo E; Garcia-Torralba E; Sorigue M; García-Malo MD; Jerez A; Vicente V; Roldán V; de Arriba F
    J Thromb Thrombolysis; 2021 Oct; 52(3):848-853. PubMed ID: 33649980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center.
    Fritz MK; Kincaid SE; Sargent CG; Green AH; Davis GA
    J Thromb Thrombolysis; 2021 Jan; 51(1):67-73. PubMed ID: 32447745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
    Thaler J; Ay C; Pabinger I
    Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns and predictors of thromboembolic events among patients with gastric cancer.
    Abdel-Razeq H; Mustafa R; Sharaf B; Al-Tell A; Braik D; Ashouri K; Omari Z; Mansour R; Qarqash J; Shaqboua H; Jaradat S; Al-Qasem K; Bater R
    Sci Rep; 2020 Oct; 10(1):18516. PubMed ID: 33116272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison among three predictive models for cancer-associated thromboembolism in a hispanic population.
    Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Céspedes-Calvo A; Mora-Hidalgo R
    J Thromb Thrombolysis; 2023 Oct; 56(3):433-438. PubMed ID: 37407771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-life use of thromboprophylaxis in patients hospitalized for pulmonary disorders: A single-center retrospective study.
    Łukaszuk RF; Plens K; Undas A
    Adv Clin Exp Med; 2018 Feb; 27(2):237-243. PubMed ID: 29521068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma.
    Rupa-Matysek J; Gil L; Barańska M; Dytfeld D; Komarnicki M
    Oncotarget; 2018 Apr; 9(30):21190-21200. PubMed ID: 29765530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Application of Existing Risk Assessment Models (RAMS) to Predict the Occurrence of Venous Thromboembolic Events among Patients with Classic Hodgkin Lymphoma.
    Ma'koseh M; Abufara A; Albaghdadi D; Ghalayni R; Abdel-Razeq S; Alzughali E; Abdel Rahman F; Alhalaseh Y; Halahleh K; Abdel-Razeq H
    J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256570
    [No Abstract]   [Full Text] [Related]  

  • 32. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients.
    Pannucci CJ; Obi A; Alvarez R; Abdullah N; Nackashi A; Hu HM; Bahl V; Henke PK
    J Am Coll Surg; 2014 May; 218(5):898-904. PubMed ID: 24680577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stratifying the risk of venous thromboembolism in otolaryngology.
    Shuman AG; Hu HM; Pannucci CJ; Jackson CR; Bradford CR; Bahl V
    Otolaryngol Head Neck Surg; 2012 May; 146(5):719-24. PubMed ID: 22261490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa.
    Wehmeyer A; Coetzee R; McCartney J
    S Afr Med J; 2022 Feb; 112(2):13506. PubMed ID: 35139994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
    Khorana AA; Francis CW; Kuderer NM; Carrier M; Ortel TL; Wun T; Rubens D; Hobbs S; Iyer R; Peterson D; Baran A; Kaproth-Joslin K; Lyman GH
    Thromb Res; 2017 Mar; 151():89-95. PubMed ID: 28139259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
    Santi RM; Ceccarelli M; Catania G; Monagheddu C; Evangelista A; Bernocco E; Monaco F; Federico M; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Calabrese M; Levis A; Visco C; Contino L; Ciccone G; Ladetto M
    Thromb Res; 2016 Apr; 140 Suppl 1():S177. PubMed ID: 27161692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies.
    Shi J; Ye J; Zhuang X; Cheng X; Fu R; Zhao A
    J Obstet Gynaecol Res; 2019 Mar; 45(3):657-664. PubMed ID: 30393982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism in lymphoma: how effectively are we treating patients?
    Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Daw HA
    Am J Clin Oncol; 2009 Oct; 32(5):521-3. PubMed ID: 19546801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.